Adma Biologics reported $34.22M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Adma Biologics USD 34.22M 77.68M Jun/2025
Alnylam Pharmaceuticals USD -66277000 8.8M Jun/2025
Dynavax Technologies USD 18.72M 114.82M Jun/2025
Takeda JPY 124.24B 227.4B Jun/2025